From the Sector

Reset
37 results
19.05.2020

Hygiene Austria LP GmbH: Production of FFP2 and mouth-nose masks

FFP2 and mouth-nose protective masks for children are also being manufactured in Wiener Neudorf

The company “Hygiene Austria LP GmbH”, recently founded by Lenzing AG and Palmers Textil AG, has once again called attention to itself. Following the successful launch of the production of mouth-nose protective masks in Austria, Hygiene Austria commenced manufacturing FFP2 masks and mouth-nose protective masks for children.
For the first time, Federal Chancellor Sebastian Kurz personally took a closer look at production operations within the context of a visit to the facility this Tuesday morning. The Austrian Chancellor visited the  Austrian company Hygiene Austria together with Federal Minister of Labor, Family and Youth Christine Aschbacher.

FFP2 and mouth-nose protective masks for children are also being manufactured in Wiener Neudorf

The company “Hygiene Austria LP GmbH”, recently founded by Lenzing AG and Palmers Textil AG, has once again called attention to itself. Following the successful launch of the production of mouth-nose protective masks in Austria, Hygiene Austria commenced manufacturing FFP2 masks and mouth-nose protective masks for children.
For the first time, Federal Chancellor Sebastian Kurz personally took a closer look at production operations within the context of a visit to the facility this Tuesday morning. The Austrian Chancellor visited the  Austrian company Hygiene Austria together with Federal Minister of Labor, Family and Youth Christine Aschbacher.

More information:
Coronavirus face masks FFP-2
Source:

Lenzing AG

The Oerlikon Nonwoven meltblown technology (c) Oerlikon
The Oerlikon Nonwoven meltblown technology
14.05.2020

Oerlikon Nonwoven deliveringmeltblown technology to FleeceforEurope

Protective masks for Europe
With FleeceforEurope and Lindenpartner, Düsseldorf-based Kloepfel Group purchasing consultancy and Berlin-based industrial consultancy Bechinger & Heymann Holding plan to manufacture and distribute up to 50 million protection class FFP1 through FFP3 respiratory masks a month exclusively for the European market from the beginning of fall. And the primary focus will be on quality.
With protective masks – including those used in operating rooms – this quality is provided above all by  virus-absorbing nonwovens. And these will be manufactured by ‘FleeceforEurope’ using an Oerlikon Nonwoven meltblown system.
But masks effectively protecting against infections can only be guaranteed with the right quality. A crucial factor in this is the inside of the mask. Because the nonwoven used in protection class FFP1 through FFP3 respiratory masks plays a decisive role.

Protective masks for Europe
With FleeceforEurope and Lindenpartner, Düsseldorf-based Kloepfel Group purchasing consultancy and Berlin-based industrial consultancy Bechinger & Heymann Holding plan to manufacture and distribute up to 50 million protection class FFP1 through FFP3 respiratory masks a month exclusively for the European market from the beginning of fall. And the primary focus will be on quality.
With protective masks – including those used in operating rooms – this quality is provided above all by  virus-absorbing nonwovens. And these will be manufactured by ‘FleeceforEurope’ using an Oerlikon Nonwoven meltblown system.
But masks effectively protecting against infections can only be guaranteed with the right quality. A crucial factor in this is the inside of the mask. Because the nonwoven used in protection class FFP1 through FFP3 respiratory masks plays a decisive role.
Here, the meltblown technology from Oerlikon Nonwoven will be deployed. In a special, patented process, the fibers laid into a nonwoven fabric during manufacture are subsequently electrostatically-charged, before the material is further processed downstream.

European market for protective masks with a promising future
Those responsible at Oerlikon Nonwoven and FleeceforEurope, which will primarily focus on producing high-end nonwovens, and Lindenpartner, which will manufacture and distribute the protective masks, are certain of one thing: the market for protective masks has a very promising long-term future in Europe.
What has been commonplace in Asia for many years now will also become normal in Europe. People will be increasingly wearing face masks when venturing out, in order to better protect themselves against health risks such as the current pandemic and also against increasing environmental pollution in the form of  fine particles and exhaust fumes in the future. A

Medical face masks from a vending machine
Mask producer Lindenpartner has already secured supplies of nonwovens and will be producing face masks for the European healthcare sector over the coming weeks. To fight the coronavirus pandemic, Lindenpartner is planning to install 100 self-service face mask vending machines in Germany over the next four weeks, positioning them in publicly-accessible places such as shopping centers and airports, for example.

Source:

Marketing, Corporate Communications & Public Affairs

Logo oerlikon
Oerlikon expands labatory capacities
30.04.2020

Oerlikon Nonwoven expands it laboratory nonwovens production capacities

Materials for in excess of one million protective masks
Within the context of supporting the critical infrastructure in Germany, Oerlikon Nonwoven immediately began converting its laboratory systems in Neumünster to manufacture nonwovens at the end of March. With this, only small local businesses and companies were initially supported in the manufacture of oronasal masks.
With the laboratory system at the R&D Center material for more than one million protective masks a month can be manufactured.

The laboratory has meanwhile run out of raw materials and new orders for replacement materials had to be placed before Easter – with current delivery times of approx. 3 weeks. This will allow production to be resumed, and even considerably expanded, in May.
The laboratory system is now once again being deployed to produce nonwovens that will be used to make more than million face masks / oronasal masks a month. “We will not be manufacturing the masks ourselves. We have meanwhile found both corresponding partner companies and also private individuals demanding nonwovens”, adds Andreas Frisch, commenting on the developments.

Materials for in excess of one million protective masks
Within the context of supporting the critical infrastructure in Germany, Oerlikon Nonwoven immediately began converting its laboratory systems in Neumünster to manufacture nonwovens at the end of March. With this, only small local businesses and companies were initially supported in the manufacture of oronasal masks.
With the laboratory system at the R&D Center material for more than one million protective masks a month can be manufactured.

The laboratory has meanwhile run out of raw materials and new orders for replacement materials had to be placed before Easter – with current delivery times of approx. 3 weeks. This will allow production to be resumed, and even considerably expanded, in May.
The laboratory system is now once again being deployed to produce nonwovens that will be used to make more than million face masks / oronasal masks a month. “We will not be manufacturing the masks ourselves. We have meanwhile found both corresponding partner companies and also private individuals demanding nonwovens”, adds Andreas Frisch, commenting on the developments.

Boom in orders
Furthermore, Oerlikon Nonwoven has also fired up the production of the machines and systems used for its meltblown technology. The demand from Germany, Europe and the rest of the world has quickly
secured the company a high in orders..
We will be commissioning the first meltblown system at the site of a leading Western European nonwovens producers in the second quarter of 2020. The capacities for respiratory masks available in Europe to date are predominantly manufactured on Oerlikon
Nonwoven systems.

Source:

Marketing, Corporate Communications & Public Affairs

Logo Mimaki
Mimaki starts to produce masks
29.04.2020

Energiapura: production of masks

Energiapura – Production of reusable, customised protective masks that are also fashion accessories

Energiapura – Production of reusable, customised protective masks that are also fashion accessories

  • The Italian company, a specialist manufacturer of functional sportswear, conducted research and began producing masks in response to the COVID-19 crisis
  • Using Mimaki sublimation printers, the masks can be customised, getting away from their connotation with hospitals and transforming them into a fashion accessory

From functional sportswear to combatting the spread of the Coronavirus: Energiapura, an Italian company has developed a mask that meets the Class I medical device requirements. The EP PA 2020 (Energiapura Pure Air) facial device, optimised for air filtering and breathability, provides protection while working, and can be reused. But Energiapura has gone even further, branding and customising the masks with sublimation printing.
The EP PA 2020 mask, compliant with 93/42 EEC Medical Devices – Class I washable, meets the essential requirements of UNI EN 14683:2019. Having redirected the manufacturing process, Energiapura is now stepping up production levels to meet the rising demand from hospitals, pharmacies, chemists, companies and consumers.

Pure Air, Energiapura’s mask
The EP PA 2020 is based on a functional concept: protection, breathability and reusability are the main principles. EP PA 2020 is made up of three layers of fabric: the first, the outer layer, is DWR-treated polyester, the second is TNT polyester, providing a filtering function, and the third, which comes into contact with the face, is polyester containing special fibres, such as coolmax and carbon.  Therefore it can be reused via normal washing and steam ironing, which also sterilises it.
The CEO of Enegiapura, Alberto Olivietto explains the idea of the customisation of the mask: “We wanted to disassociate our masks from the hospital image. By decorating them with company branding and designs provided by customers.” This is where the Mimaki JV300 wide-format printer comes in.

 

More information:
corona virus face masks
Source:

(c) Mimaki Europe B.V.

27.04.2020

Using chemistry to fight Covid-19: CHT Group expands product portfolio

In mid-March, CHT Germany GmbH, which specializes in specialty chemicals, took up production and distribution of hand disinfectant. Now the company is expanding its product portfolio by adding important medical supplies that can help fight Covid-19 (SARS-CoV-2). Starting immediately, CHT is providing its business customers with surface disinfectant, textile supplies for medical protective wear as well as supplies for test kits and face masks.

In mid-March, CHT Germany GmbH, which specializes in specialty chemicals, took up production and distribution of hand disinfectant. Now the company is expanding its product portfolio by adding important medical supplies that can help fight Covid-19 (SARS-CoV-2). Starting immediately, CHT is providing its business customers with surface disinfectant, textile supplies for medical protective wear as well as supplies for test kits and face masks.

Following increased demand for disinfectant in the wake of the new coronavirus, the CHT Group began already a month and a half ago to produce hand disinfectant at its factory in Dußlingen. Since then, more of its factories around the world had joined in. Now the CHT Group is complementing this offering by producing its own surface disinfectant based on ethanol. As with the hand disinfectant, the production of the surface disinfectant received a special approval, based on the expanded general ruling by the German Federal Agency  for Chemicals (BAuA). Both types of disinfectant use publicly available standard formulas for alcohol-based disinfectant from the World Health Organization (WHO). The sale of CHT’s surface disinfectant, which is available in 5-, 10- and 30-liter canisters, is exclusively for use by industry customers.

In addition, the CHT Group is manufacturing a range of textile-relevant products that provide protection from Covid-19. These include functional supplies for face masks for medical protective wear, as well as flocking for test kits. Through these offerings, the CHT Group also wants to support the textile sector, which has been strongly affected by the crisis.

More information:
surface disinfectant CHT Gruppe
Source:

CHT Gruppe

24.04.2020

Lenzing AG and Palmers Textil AG found Hygiene Austria LP GmbH

Center of competence for hygiene established in Wiener Neudorf to support Austria and the EU in the Covid-19 crisis for the industrial production of high-quality protective masks with a monthly capacity of 12 million pieces.

Lenzing AG and Palmers Textil AG found “Hygiene Austria LP GmbH”, in which Lenzing AG holds 50.1% and Palmers Textil AG 49.9%. The newly founded company will start producing and selling protective masks for the domestic and European markets from May 2020.

Over the past few weeks, Lenzing AG and Palmers Textil AG have invested several million euros in a modern production infrastructure at the Wiener Neudorf location and secured the corresponding raw materials for protective masks production. In a first step, the company produces so-called mouth-nose protective masks (MNS) and surgical protective masks of class EN14683. Hygiene Austria LP GmbH plans to increase its capacities to over 25 million masks per month over the next few weeks and to expand this business geographically as well.

Center of competence for hygiene established in Wiener Neudorf to support Austria and the EU in the Covid-19 crisis for the industrial production of high-quality protective masks with a monthly capacity of 12 million pieces.

Lenzing AG and Palmers Textil AG found “Hygiene Austria LP GmbH”, in which Lenzing AG holds 50.1% and Palmers Textil AG 49.9%. The newly founded company will start producing and selling protective masks for the domestic and European markets from May 2020.

Over the past few weeks, Lenzing AG and Palmers Textil AG have invested several million euros in a modern production infrastructure at the Wiener Neudorf location and secured the corresponding raw materials for protective masks production. In a first step, the company produces so-called mouth-nose protective masks (MNS) and surgical protective masks of class EN14683. Hygiene Austria LP GmbH plans to increase its capacities to over 25 million masks per month over the next few weeks and to expand this business geographically as well.

The demand for high-quality MNS and respiratory masks for medical personnel is increasing rapidly, and there is real competition on the international market for these products. In order to sustainably secure domestic supply now and in the future and to strengthen the business location, the two companies Lenzing AG and Palmers Textil AG have now set a milestone with their own competence center for hygiene based in Austria.

Hygiene Austria LP GmbH thus makes a significant contribution to combating the Covid-19 pandemic and ensures the long-term supply of these critical goods in Austria in high quality.

Source:

Lenzing AG

Logo monforts
Logo monforts
21.04.2020

Monforts: Industrial-scale testing for new PPE finishes

In the current fight against Covid-19, a number of formulators of textile finishing chemicals have rushed out new antiviral and antimicrobial treatments intended for PPE (personal protective equipment) such as face masks and medical gowns and drapes.

These finishing chemicals have naturally already been thoroughly tested in laboratories and their effectiveness verified at laboratory or pilot scale. However, they are new to many manufacturers of textiles and nonwovens now preparing to use them on an industrial level.

A lot of companies changed, due to the current situation their usual manufacturing programmes to the production of PPE items. “We have experts on hand at our operational Advanced Technology Centre (ATC) here in Germany, to help any of our customers to rapidly transition to new finishing techniques and treatments they may not be familiar with, and to run trials on their behalf, should they require this assistance.”, states the vice president of Monforts, Klaus Heinrichs.

In the current fight against Covid-19, a number of formulators of textile finishing chemicals have rushed out new antiviral and antimicrobial treatments intended for PPE (personal protective equipment) such as face masks and medical gowns and drapes.

These finishing chemicals have naturally already been thoroughly tested in laboratories and their effectiveness verified at laboratory or pilot scale. However, they are new to many manufacturers of textiles and nonwovens now preparing to use them on an industrial level.

A lot of companies changed, due to the current situation their usual manufacturing programmes to the production of PPE items. “We have experts on hand at our operational Advanced Technology Centre (ATC) here in Germany, to help any of our customers to rapidly transition to new finishing techniques and treatments they may not be familiar with, and to run trials on their behalf, should they require this assistance.”, states the vice president of Monforts, Klaus Heinrichs.

The three lines at the ATC situated at the Monforts HQ in Mönchengladbach, are of a true industrial scale and trialling new products on them goes beyond lab or pilot plant testing to rapidly identify any problems that might occur once full production is underway.

 

More information:
Monforts corona virus
Source:

AWOL Media

16.04.2020

SANITIZED AG aids measures to promote hygiene management during the coronavirus pandemic

  • Antiviral properties of Sanitized® products on synthetics validated

Tests conducted by independent laboratories have now confirmed that a treatment with Sanitized® T 99-19 and Sanitized® T 11-15 reduces the viral load on PES textiles by
up to 99 %.

Swiss company SANITIZED AG announces the validation from impartial labs that Sanitized®T 99-19 and Sanitized®T 11-15 are also effective against viruses (in accordance with ISO 18184:2019). Tests were performed using a feline coronavirus with structures and mechanisms reminiscent of SARS-Cov2. Patented technology featuring an ammonium silicate compound  is employed in Sanitized®T 99-19 and Sanitized®T 11-15 utilizes tried and tested silver technology.

These additives are the perfect tool for an antiviral and antibacterial treatment of face masks, protective professional medical clothing, bed linens, or mattresses. The formulation of both products remains completely untouched, thus ensuring that it will continue to offer outstanding protection against bacteria.

  • Antiviral properties of Sanitized® products on synthetics validated

Tests conducted by independent laboratories have now confirmed that a treatment with Sanitized® T 99-19 and Sanitized® T 11-15 reduces the viral load on PES textiles by
up to 99 %.

Swiss company SANITIZED AG announces the validation from impartial labs that Sanitized®T 99-19 and Sanitized®T 11-15 are also effective against viruses (in accordance with ISO 18184:2019). Tests were performed using a feline coronavirus with structures and mechanisms reminiscent of SARS-Cov2. Patented technology featuring an ammonium silicate compound  is employed in Sanitized®T 99-19 and Sanitized®T 11-15 utilizes tried and tested silver technology.

These additives are the perfect tool for an antiviral and antibacterial treatment of face masks, protective professional medical clothing, bed linens, or mattresses. The formulation of both products remains completely untouched, thus ensuring that it will continue to offer outstanding protection against bacteria.

Before a final product’s antiviral properties can be publicly promoted, viral tests must be performed in specialized laboratories. Compliance with local legal regulations is essential here. SANITIZED AG explicitly points out that this is standard procedure and has composed a preliminary Guide for Treating PPE (personal protective equipment) with biocide products.

Guide Link: https://campaign.sanitized.com/en/treatment-of-ppe-with-biocidal-products

More information:
Coronavirus
Source:

PR-Büro Heinhöfer

Logo Sanitized
Logo Sanitized
16.04.2020

Sanitized: Antiviral properties of Sanitized® products on synthetics

Tests conducted by independent laboratories have now confirmed that a treatment with Sanitized® T 99-19 and Sanitized® T 11-15 reduces the viral load on PES textiles by up to 99 %.

Swiss company SANITIZED AG celebrates validation from impartial labs that Sanitized®T 99-19 and Sanitized®T 11-15 are also effective against viruses (in accordance with ISO 18184:2019).
Tests were performed using a feline coronavirus with structures and mechanisms reminiscent of SARS-Cov2.

Patented technology featuring an ammonium silicate compound is employed in Sanitized®T 99-19 and Sanitized®T 11-15 utilizes tried and tested silver technology. These additives are the perfect tool for an antiviral and antibacterial treatment of face masks, protective professional medical clothing, bed linens, or mattresses.
The formulation of both products remains completely untouched, thus ensuring that it will continue to offer outstanding protection against bacteria.

Tests conducted by independent laboratories have now confirmed that a treatment with Sanitized® T 99-19 and Sanitized® T 11-15 reduces the viral load on PES textiles by up to 99 %.

Swiss company SANITIZED AG celebrates validation from impartial labs that Sanitized®T 99-19 and Sanitized®T 11-15 are also effective against viruses (in accordance with ISO 18184:2019).
Tests were performed using a feline coronavirus with structures and mechanisms reminiscent of SARS-Cov2.

Patented technology featuring an ammonium silicate compound is employed in Sanitized®T 99-19 and Sanitized®T 11-15 utilizes tried and tested silver technology. These additives are the perfect tool for an antiviral and antibacterial treatment of face masks, protective professional medical clothing, bed linens, or mattresses.
The formulation of both products remains completely untouched, thus ensuring that it will continue to offer outstanding protection against bacteria.

Before a final product’s antiviral properties can be publicly promoted, viral tests must be performed in specialized laboratories. Compliance with local legal regulations is essential here. SANITIZED AG explicitly points out that this is standard procedure and has composed a preliminary Guide for Treating PPE

SANITIZED AG has been supporting the work of hygienists in hospitals, doctor’s offices, nursing and care facilities for many years with its antimicrobial - and now also antiviral - additives used to enhance the
functionality of textiles and polymers. The reduction of bacteria and viruses is a feasible way to help stem the spread of infections including MRSA.

Source:

PR-Büro Heinhöfer

Logos of the participating companies
Gerber PPE Task Force
08.04.2020

A&E and Burlington participate in the Gerber PPE Task Force

Elevate Textiles, a global provider of advanced, high quality products and mission critical textile solutions is pleased to participate in the recently launched Gerber PPE Task Force. This industry-wide effort combines resources and expertise to support manufacturing operations and brands as they increase their production or transition their operations to produce personal protective equipment in the fight against COVID-19.
Elevate’s Burlington, American & Efird (A&E), and Gütermann brands provide critical barrier fabric and thread components used in the manufacturing of lifesaving PPE products including masks, isolation gowns and other medical garments.

"The only way to be successful during this difficult situation is to join forces and support one another," said Lenny Marano, VP of Product Management & Marketing for Automation Systems at Gerber Technology. "We are proud to have a global network of partners to support PPE production so that it's more widely available."

Elevate Textiles, a global provider of advanced, high quality products and mission critical textile solutions is pleased to participate in the recently launched Gerber PPE Task Force. This industry-wide effort combines resources and expertise to support manufacturing operations and brands as they increase their production or transition their operations to produce personal protective equipment in the fight against COVID-19.
Elevate’s Burlington, American & Efird (A&E), and Gütermann brands provide critical barrier fabric and thread components used in the manufacturing of lifesaving PPE products including masks, isolation gowns and other medical garments.

"The only way to be successful during this difficult situation is to join forces and support one another," said Lenny Marano, VP of Product Management & Marketing for Automation Systems at Gerber Technology. "We are proud to have a global network of partners to support PPE production so that it's more widely available."

For over 40 years, Burlington has been in the Medical business manufacturing fabrics for use in operating theaters such as surgeon’s gowns, isolation gowns, sterilization wrapper packs, drapes, scrubs and lab coats. The Maxima® collection of fabrics is useful for reusable isolation and surgical gowns and meets AAMI standards for Levels 1-4 and FDA standards.

Source:

American & Efird

Meltblown Vliesstoffanlagen von Oerlikon Nonwoven (c) Oerlikon Manmade fibers
Meltblown Vliesstoffanlagen von Oerlikon Nonwoven
02.04.2020

Oerlikon Nonwoven large-scale meltblown sold to Asia

a leading Asian large-scale manufacturer of manmade fibers and polymers has invested in a new Oerlikon Nonwoven meltblown system. The recently-signed contract comprises a 2-beam system for manufacturing filtration nonwovens – predominantly for medical products such as face masks – with a nominal capacity of up to 1,200 tons of nonwovens a year. The commercial production launch has been scheduled for the fourth quarter of 2020.

The 2-beam system has an operating width of 1.6 meters and is equipped with the new patented Oerlikon Nonwoven electro-charging unit. The Oerlikon Nonwoven meltblown technology is recognized by the market as being the technically most efficient method for producing highly-separating filter media made from manmade fibers, particularly in conjunction with electrostatic charging and with extremely low-pressure loss. Electro-charging the filter nonwovens allows the manufacture of sophisticated EPA- and HEPA-class filter media as well as media that comply with the requirements of N95-, FFP2- and FFP3-class respiratory masks.

a leading Asian large-scale manufacturer of manmade fibers and polymers has invested in a new Oerlikon Nonwoven meltblown system. The recently-signed contract comprises a 2-beam system for manufacturing filtration nonwovens – predominantly for medical products such as face masks – with a nominal capacity of up to 1,200 tons of nonwovens a year. The commercial production launch has been scheduled for the fourth quarter of 2020.

The 2-beam system has an operating width of 1.6 meters and is equipped with the new patented Oerlikon Nonwoven electro-charging unit. The Oerlikon Nonwoven meltblown technology is recognized by the market as being the technically most efficient method for producing highly-separating filter media made from manmade fibers, particularly in conjunction with electrostatic charging and with extremely low-pressure loss. Electro-charging the filter nonwovens allows the manufacture of sophisticated EPA- and HEPA-class filter media as well as media that comply with the requirements of N95-, FFP2- and FFP3-class respiratory masks.

The demand for filtration nonwovens for medical applications has risen tremendously across the globe since the outbreak of the Sars-CoV-2 (coronavirus) epidemic, presenting all manufacturers with huge challenges. A meltblown system will be commissioning at the site of a leading Western European nonwovens producers as early as the second quarter of 2020. This system will be deployed exclusively in the manufacture of nonwovens for respiratory masks.

Due to the current state of emergency with regards to the local supply of face masks, Oerlikon Nonwoven is currently using its own laboratory system to produce electrostatically-charged filter media which are being sent to local small businesses and companies for the manufacture of face masks. 

 

More information:
Oerlikon Nonwoven
Source:

Oerlikon Manmade fibers

Face Mask Production in Denim Expert Ltd (c) Denim Expert Ltd
Face Mask Production in Denim Expert Ltd
26.03.2020

Denim Expert Ltd are producing facing mask for safety issue

  • Bangladeshi supplier offers production capacity to produce face masks and PPE on a non-profit basis
  • Reaching out to global agencies to build partnerships to help tackle COVID-19 crisis
  • “Now is the time for our whole industry to stand together”

A leading Bangladeshi garment manufacturer is offering the manufacturing capacity of his world-class facility for the production of protective face masks and Personal Protective Equipment (PPE) on a non-profit basis to help tackle the COVID-19 global pandemic.

Denim Expert Limited Managing Director, Mostafiz Uddin, has reached out to the global community including brands & retailers, governments, embassies, donors, development agencies, global apparel associations and bodies in these unprecedented times.

Mr. Uddin is offering the capacity, skills and production expertise of his factory and wants to develop partnerships to meet much-needed short-term demand for masks and PPE in the battle against COVID-19.

  • Bangladeshi supplier offers production capacity to produce face masks and PPE on a non-profit basis
  • Reaching out to global agencies to build partnerships to help tackle COVID-19 crisis
  • “Now is the time for our whole industry to stand together”

A leading Bangladeshi garment manufacturer is offering the manufacturing capacity of his world-class facility for the production of protective face masks and Personal Protective Equipment (PPE) on a non-profit basis to help tackle the COVID-19 global pandemic.

Denim Expert Limited Managing Director, Mostafiz Uddin, has reached out to the global community including brands & retailers, governments, embassies, donors, development agencies, global apparel associations and bodies in these unprecedented times.

Mr. Uddin is offering the capacity, skills and production expertise of his factory and wants to develop partnerships to meet much-needed short-term demand for masks and PPE in the battle against COVID-19.

Those willing to partner with him and wishing to utilize his production capacity would only be asked to provide fabrics and raw materials as well as meeting workers’ wages.

More information:
Denim Expert Ltd.
Source:

Denim Expert Ltd

Denim Expert Ltd Logo
Denim Expert Ltd. starts to produce face masks
25.03.2020

Denim Expert Ltd: production of face masks and PPE

  • Bangladeshi supplier offers production capacity to produce face masks and PPE on non-profit basis
  •  Reaching out to global agencies to build partnerships to help tackle COVID-19 crisis

A Bangladeshi garment manufacturer is offering the manufacturing capacity for the production of protective face masks and Personal Protective Equipment (PPE) on a non-profit basis to help tackle the COVID-19 global pandemic.
Many hospitals in Europe and USA are already running short of masks and PPE as they creak under the strain of the pandemic.
At present, COVID-19 is most prevalent in Europe, where demand for surgical masks and other protective garments has increased this past two months. However, other countries – including Bangladesh – are several weeks behind Europe but are expected to follow the same pattern in terms of cases and deaths.

Denim Expert Limited Managing Director, Mostafiz Uddin, has reached out to the global community including brands & retailers, governments, embassies, donors, development agencies, global apparel associations and bodies in these unprecedented times.

 

 

  • Bangladeshi supplier offers production capacity to produce face masks and PPE on non-profit basis
  •  Reaching out to global agencies to build partnerships to help tackle COVID-19 crisis

A Bangladeshi garment manufacturer is offering the manufacturing capacity for the production of protective face masks and Personal Protective Equipment (PPE) on a non-profit basis to help tackle the COVID-19 global pandemic.
Many hospitals in Europe and USA are already running short of masks and PPE as they creak under the strain of the pandemic.
At present, COVID-19 is most prevalent in Europe, where demand for surgical masks and other protective garments has increased this past two months. However, other countries – including Bangladesh – are several weeks behind Europe but are expected to follow the same pattern in terms of cases and deaths.

Denim Expert Limited Managing Director, Mostafiz Uddin, has reached out to the global community including brands & retailers, governments, embassies, donors, development agencies, global apparel associations and bodies in these unprecedented times.

 

 

Source:

Denim Expert Ltd.

25.03.2020

DEVAN: Antiviral solutions for textiles

Textile innovator and specialty chemical producer Devan answers questions regarding anti-viral textile finish solutions following the growing spread of the COVID-19 outbreak.

Devan studied enveloped viruses (e.g. H1N1, Corona-types etc.) as well as naked viruses (e.g. Rotavirus). For both virus families BI-OME AV showed strong activity in wet state.
In the first instance, the company wants to focus on professionals who need to stay working such as policemen, logistics workers, shop employees, day-care workers.

A common complication of respiratory viral disease can be a secondary bacterial infection. Professionals could be helped with either an anti-bacterial on their facemask to reduce the chance for these secondary bacterial infections, for better hygiene and less odour build-up. On workwear, a combination of a virus spread reducing and antibacterial solution could help as these garments are typically used during long hours, are non-disposable and most likely will be washed at home.
 

Textile innovator and specialty chemical producer Devan answers questions regarding anti-viral textile finish solutions following the growing spread of the COVID-19 outbreak.

Devan studied enveloped viruses (e.g. H1N1, Corona-types etc.) as well as naked viruses (e.g. Rotavirus). For both virus families BI-OME AV showed strong activity in wet state.
In the first instance, the company wants to focus on professionals who need to stay working such as policemen, logistics workers, shop employees, day-care workers.

A common complication of respiratory viral disease can be a secondary bacterial infection. Professionals could be helped with either an anti-bacterial on their facemask to reduce the chance for these secondary bacterial infections, for better hygiene and less odour build-up. On workwear, a combination of a virus spread reducing and antibacterial solution could help as these garments are typically used during long hours, are non-disposable and most likely will be washed at home.
 

More information:
Devan face masks antiviral
Source:

Marketing Solutions NV

NCTO (c) NCTO
23.03.2020

Beverly Knits Inc. produces face masks for health care workers

Beverly Knits Inc. is proud to be involved in the effort led by Hanes and Parkdale to help support the fight against COVID-19. Working with a coalition of textile companies, we are ramping up production in the USA to provide face masks for health care workers on the frontlines. With the combined efforts of many small and medium-size companies, we are retooling our production lines to begin manufacturing immediately.

Beverly Knits is coordinating the production of up to 1.5 million masks produced domestically per week. Ron Sytz, CEO of Beverly Knits, said “It is an honor to be working with great American companies, united to supply critical resources to healthcare workers and first responders”.

Companies on the Beverly Knits team

  • Clover Knits
  • Contempora Knits
  • Carolina Cotton Works
  • Southfork Finishing
  • National Safety Apparel
  • A Lava & Sons
  • Wells Hosiery
  • Jomel Industries
  • LA Corp
  • Greenwood Mills

 

Beverly Knits Inc. is proud to be involved in the effort led by Hanes and Parkdale to help support the fight against COVID-19. Working with a coalition of textile companies, we are ramping up production in the USA to provide face masks for health care workers on the frontlines. With the combined efforts of many small and medium-size companies, we are retooling our production lines to begin manufacturing immediately.

Beverly Knits is coordinating the production of up to 1.5 million masks produced domestically per week. Ron Sytz, CEO of Beverly Knits, said “It is an honor to be working with great American companies, united to supply critical resources to healthcare workers and first responders”.

Companies on the Beverly Knits team

  • Clover Knits
  • Contempora Knits
  • Carolina Cotton Works
  • Southfork Finishing
  • National Safety Apparel
  • A Lava & Sons
  • Wells Hosiery
  • Jomel Industries
  • LA Corp
  • Greenwood Mills

 

More information:
Beverly Knits Inc. NCTO
Source:

NCTO

NCTO Logo (c) NCTO
NCTO Logo
20.03.2020

U.S. Textile and Nonwoven Associations Urge Government to Deem Manufacturing

Textile and nonwoven associations issued a joint statement today urging federal, state and local governments to deem textile and nonwoven manufacturing facilities as “essential” when drafting “Shelter in Place” orders in response to the COVID-19 crisis.

Our associations recognize the serious challenges our elected officials, health administrators, and others are facing when issuing orders to protect communities across the country and we understand the necessity for leaders to enforce a ‘Shelter in Place” order or quarantine orders.

Our members make a broad range of inputs and finished products used in an array of personal protective equipment (PPE) and medical nonwoven/textile supplies, including surgical gowns, face masks, antibacterial wipes, lab coats, blood pressure cuffs, cotton swabs and hazmat suits. These items are vital to the government’s effort to ramp up emergency production of these critical supplies.

Textile and nonwoven associations issued a joint statement today urging federal, state and local governments to deem textile and nonwoven manufacturing facilities as “essential” when drafting “Shelter in Place” orders in response to the COVID-19 crisis.

Our associations recognize the serious challenges our elected officials, health administrators, and others are facing when issuing orders to protect communities across the country and we understand the necessity for leaders to enforce a ‘Shelter in Place” order or quarantine orders.

Our members make a broad range of inputs and finished products used in an array of personal protective equipment (PPE) and medical nonwoven/textile supplies, including surgical gowns, face masks, antibacterial wipes, lab coats, blood pressure cuffs, cotton swabs and hazmat suits. These items are vital to the government’s effort to ramp up emergency production of these critical supplies.

If workers who produce these goods are not granted an “essential” exemption from “Shelter in Place” and other quarantine orders to go to their manufacturing and distribution facilities, it will cause major disruptions in the availability of these goods. This will create significant hardship to healthcare providers and consumers across the country who depend on steady and stable supplies of these critical items.

We are asking the administration and state and local authorities to provide greater certainty and clarity for our companies and employees and ask for a clear exclusion of our manufacturing operations from “Shelter in Place” orders as the textile and nonwoven products that we make in the U.S. play an essential role in mitigating the shortages of critical supplies. Such a designation will help us avoid disruptions of vital goods and services during this challenging time.

Source:

NCTO

IFAI 

INDA

From left: Carlo Centonze, Dr. Thierry Pelet holding the first prototype of HeiQ Viroblock NPJ03 treated face masks (c) HeiQ
From left: Carlo Centonze, Dr. Thierry Pelet holding the first prototype of HeiQ Viroblock NPJ03 treated face masks
17.03.2020

HeiQ Viroblock NPJ03 antiviral textile technology tested effective against Coronavirus

HeiQ, winner of the Swiss Technology Award and Swiss Environmental Award, launches HeiQ Viroblock NPJ03, an antiviral and antimicrobial textile treatment that is tested effective against coronavirus.

Since its inception 15 years ago, HeiQ has forged a solid innovation track record helping brands improve textile products. Catalyzed to action by the global fight against Coronavirus, HeiQ launches HeiQ Viroblock NPJ03, an antiviral and antimicrobial textile treatment which is proven effective against human coronavirus (229E) in face mask testing, significantly enhancing the antiviral log reduction from 2.90 of untreated face masks to 4.48, over 99.99% reduction of virus infectivity. (Remarks: a log reduction of 2 is equivalent to 100 times the effectiveness).

Chinese protective masks producer Suzhou Bolisi is the lead adopter of HeiQ Viroblock NPJ03. Treated masks will be available on the market as early as this April. American legwear manufacturer Kayser-Roth is planning to add the technology to their new product, Ghluv hands protector, while Lufeng from China is evaluating the technology on other types of fabric used for garments.

HeiQ, winner of the Swiss Technology Award and Swiss Environmental Award, launches HeiQ Viroblock NPJ03, an antiviral and antimicrobial textile treatment that is tested effective against coronavirus.

Since its inception 15 years ago, HeiQ has forged a solid innovation track record helping brands improve textile products. Catalyzed to action by the global fight against Coronavirus, HeiQ launches HeiQ Viroblock NPJ03, an antiviral and antimicrobial textile treatment which is proven effective against human coronavirus (229E) in face mask testing, significantly enhancing the antiviral log reduction from 2.90 of untreated face masks to 4.48, over 99.99% reduction of virus infectivity. (Remarks: a log reduction of 2 is equivalent to 100 times the effectiveness).

Chinese protective masks producer Suzhou Bolisi is the lead adopter of HeiQ Viroblock NPJ03. Treated masks will be available on the market as early as this April. American legwear manufacturer Kayser-Roth is planning to add the technology to their new product, Ghluv hands protector, while Lufeng from China is evaluating the technology on other types of fabric used for garments.

HeiQ Viroblock NPJ03 is a unique combination of vesicle and silver technologies designed to inhibit the growth and persistence of bacteria and viruses. The HeiQ vesicle technology targets lipid- enveloped viruses, such as coronavirus, providing rapid virus deactivation, while the HeiQ silver technology inhibits the replication of both bacteria and viruses. HeiQ Viroblock NPJ03 can be applied to a wide spectrum of textile surfaces including face masks, air filters, medical gowns, curtains, drapes and more. HeiQ also has a range of highly wash-durable antimicrobial and odor control textile technologies, called HeiQ Pure, combining silver-based and bio-based materials for all fabric types.

More information:
HeiQ Coronavirus
Source:

HeiQ